Literature DB >> 7134810

Hepatic galactose elimination kinetics in the intact pig.

S Keiding, S Johansen, K Winkler.   

Abstract

The hepatic galactose elimination kinetics was studied in eight anaesthetized pigs by hepatic vein catheterization. Galactose was given as successive constant intravenous infusions so that steady-state concentrations, ranging from 50 mumol/l to 8 mmol/l, were obtained. Concentrations were measured in a peripheral artery and in the hepatic veins. Hepatic blood flow was determined by constant infusion of indocyanine green. The elimination kinetics is described by a mathematical model which assumes that the liver sinusoids are perfused with unidirectional blood flow and that the elimination in the hepatocytes takes place according to Michaelis-Menten kinetics. This creates a decreasing sinusoidal blood concentration from the inlet to the outlet of the liver. The estimated maximal elimination rate, Vmax, was on average 0.67 mmol min-1 kg-1 liver (range 0.55-0.95) and the half saturation concentration Km 0.25 mmol/l (0.12-0.58). The estimate of Km is similar to the value found in the isolated perfused pig liver (0.23 mmol/l), whereas the estimate of Vmax is about 50% higher (0.43 mmol min-1 kg-1 liver), probably due to both extrahepatic elimination in the splanchnic area and a better function of the liver in situ than in the isolated preparation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7134810

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  8 in total

1.  Analogue tracers and lumped constant in capillary beds.

Authors:  Ludvik Bass; Michael Sørensen; Ole Lajord Munk; Susanne Keiding
Journal:  J Theor Biol       Date:  2011-07-05       Impact factor: 2.691

2.  Effect of plasma protein binding on elimination of taurocholate by isolated perfused rat liver: comparison of venous equilibrium, undistributed and distributed sinusoidal, and dispersion models.

Authors:  R H Smallwood; D J Morgan; G W Mihaly; D B Jones; R A Smallwood
Journal:  J Pharmacokinet Biopharm       Date:  1988-08

3.  Hepatic galactose metabolism quantified in humans using 2-18F-fluoro-2-deoxy-D-galactose PET/CT.

Authors:  Michael Sørensen; Kasper Sandager Mikkelsen; Kim Frisch; Ludvik Bass; Bo Martin Bibby; Susanne Keiding
Journal:  J Nucl Med       Date:  2011-08-29       Impact factor: 10.057

4.  Determination of hepatic galactose elimination capacity using 2-[¹⁸F]fluoro-2-deoxy-D-galactose PET/CT: reproducibility of the method and metabolic heterogeneity in a normal pig liver model.

Authors:  Michael Sørensen
Journal:  Scand J Gastroenterol       Date:  2010-08-09       Impact factor: 2.423

Review 5.  Bringing physiology into PET of the liver.

Authors:  Susanne Keiding
Journal:  J Nucl Med       Date:  2012-02-09       Impact factor: 10.057

Review 6.  Quantitative PET of liver functions.

Authors:  Susanne Keiding; Michael Sørensen; Kim Frisch; Lars C Gormsen; Ole Lajord Munk
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-04-25

7.  Hepatic uptake and metabolism of galactose can be quantified in vivo by 2-[18F]fluoro-2-deoxygalactose positron emission tomography.

Authors:  Michael Sørensen; Ole Lajord Munk; Frank Viborg Mortensen; Aage Kristian Olsen; Dirk Bender; Ludvik Bass; Susanne Keiding
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-05-15       Impact factor: 4.052

8.  Modelling severe Staphylococcus aureus sepsis in conscious pigs: are implications for animal welfare justified?

Authors:  Helle G Olsen; Mads Kjelgaard-Hansen; Pernille Tveden-Nyborg; Malene M Birck; Karsten P Hammelev; Andreas Vegge; Bent Aalbæk; Páll S Leifsson; Henrik E Jensen; Tine Iburg; Peter M H Heegaard; Ole L Nielsen
Journal:  BMC Res Notes       Date:  2016-02-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.